ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VOR Vor Biopharma Inc

1.7062
0.0062 (0.36%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 154,391
Bid Price 1.68
Ask Price 2.58
News -
Day High 1.719

Low
1.62

52 Week Range

High
5.70

Day Low 1.65
Share Name Share Symbol Market Stock Type
Vor Biopharma Inc VOR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0062 0.36% 1.7062 23:00:08
Open Price Low Price High Price Close Price Previous Close
1.71 1.65 1.719 1.69 1.70
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,231 154,391 US$ 1.68 US$ 259,601 - 1.62 - 5.70
Last Trade Type Quantity Price Currency
16:36:32 5 US$ 1.69 USD

Vor Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
114.59M 67.81M - 0 -117.86M -1.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vor Biopharma News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VOR Message Board. Create One! See More Posts on VOR Message Board See More Message Board Posts

Historical VOR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.671.951.651.77221,7350.03622.17%
1 Month2.422.431.651.97281,379-0.7138-29.50%
3 Months2.312.431.652.05344,026-0.6038-26.14%
6 Months2.213.13991.622.09244,688-0.5038-22.80%
1 Year4.345.701.622.69196,493-2.63-60.69%
3 Years30.0431.201.626.57150,558-28.33-94.32%
5 Years42.0263.621.6210.71159,475-40.31-95.94%

Vor Biopharma Description

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Your Recent History

Delayed Upgrade Clock